• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015.韩国实施十余年水痘单剂疫苗普遍接种前后(2003-2015 年)水痘和带状疱疹流行病学趋势。
Hum Vaccin Immunother. 2019;15(11):2554-2560. doi: 10.1080/21645515.2019.1603985. Epub 2019 May 7.
2
Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study.澳大利亚实施单剂量水痘疫苗接种前后的水痘和带状疱疹住院情况:一项生态学研究。
Bull World Health Organ. 2014 Aug 1;92(8):593-604. doi: 10.2471/BLT.13.132142. Epub 2014 Jun 13.
3
The changing epidemiology of herpes zoster over a decade in South Korea, 2006-2015.韩国十余年来带状疱疹的流行情况变化:2006-2015 年。
Vaccine. 2019 Aug 23;37(36):5153-5160. doi: 10.1016/j.vaccine.2019.07.086. Epub 2019 Jul 31.
4
The epidemiologic and economic impact of varicella and herpes zoster vaccination in South Korea: A mathematical modelling study.韩国水痘和带状疱疹疫苗接种的流行病学和经济影响:一项数学建模研究。
Vaccine. 2024 Jul 25;42(19):4046-4055. doi: 10.1016/j.vaccine.2024.05.016. Epub 2024 May 18.
5
Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.德国水痘和带状疱疹疫苗接种的当前及未来影响——来自一个水痘普遍接种国家的数学模型的见解
Hum Vaccin Immunother. 2016 Jul 2;12(7):1766-76. doi: 10.1080/21645515.2015.1135279. Epub 2016 Feb 2.
6
Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.在瑞典,水痘和带状疱疹疫苗接种的成本效益:使用动态传播模型进行的经济评估。
PLoS One. 2021 May 13;16(5):e0251644. doi: 10.1371/journal.pone.0251644. eCollection 2021.
7
The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003.1998年至2003年期间,在水痘疫苗接种率不断上升的情况下,马萨诸塞州通过行为危险因素监测系统(BRFSS)测量的水痘和带状疱疹发病率。
BMC Public Health. 2005 Jun 16;5:68. doi: 10.1186/1471-2458-5-68.
8
The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics.使用人口统计学变化的数学模型评估韩国两剂水痘疫苗接种对水痘和带状疱疹发病率的影响。
Vaccine. 2021 Apr 28;39(18):2575-2583. doi: 10.1016/j.vaccine.2021.03.056. Epub 2021 Apr 1.
9
Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.巴西水痘和带状疱疹住院治疗的普遍水痘疫苗接种的早期影响。
Vaccine. 2018 Jan 4;36(2):280-284. doi: 10.1016/j.vaccine.2017.11.057. Epub 2017 Dec 1.
10
Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.德国人口结构变化对水痘和带状疱疹疫苗接种影响的研究——一项数学建模研究
BMC Med. 2018 Jan 9;16(1):3. doi: 10.1186/s12916-017-0983-5.

引用本文的文献

1
Burden of Herpes Zoster in Individuals With Chronic Conditions in the Republic of Korea: A Nationwide Population-Based Database Study.韩国慢性病患者的带状疱疹负担:一项基于全国人口数据库的研究。
Open Forum Infect Dis. 2024 Sep 18;11(10):ofae535. doi: 10.1093/ofid/ofae535. eCollection 2024 Oct.
2
A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific.亚太地区部分地区带状疱疹的流行病学和疾病负担的系统文献回顾。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2344983. doi: 10.1080/21645515.2024.2344983. Epub 2024 May 20.
3
Epidemiological Characteristics of Varicella in Anhui Province, China, 2012-2021: Surveillance Study.中国安徽省 2012-2021 年水痘的流行病学特征:监测研究。
JMIR Public Health Surveill. 2024 Apr 5;10:e50673. doi: 10.2196/50673.
4
Burden of Herpes Zoster in Individuals with Immunocompromised Conditions and Autoimmune Diseases in the Republic of Korea: A Nationwide Population-Based Database Study.韩国免疫功能低下者和自身免疫性疾病患者带状疱疹负担:一项基于全国人口数据库的研究。
Infect Dis Ther. 2023 Dec;12(12):2771-2790. doi: 10.1007/s40121-023-00894-y. Epub 2023 Dec 12.
5
Seroprevalence of Varicella-Zoster Virus and Measles among Healthcare Workers in a Tertiary Medical Center in Korea.韩国一家三级医疗中心医护人员中水痘-带状疱疹病毒和麻疹的血清流行率
Vaccines (Basel). 2022 Nov 18;10(11):1956. doi: 10.3390/vaccines10111956.
6
Comparing Prodrugs with Acyclovir for Treating Postherpetic Neuralgia among Herpes Zoster Patients: A Systematic Review and Meta-Analysis.比较前体药物与阿昔洛韦治疗带状疱疹患者带状疱疹后神经痛的疗效:一项系统评价和荟萃分析。
Healthcare (Basel). 2022 Jun 24;10(7):1181. doi: 10.3390/healthcare10071181.
7
Case Report: Various Clinical Manifestations Caused by Varicella-Zoster Virus in a Family.病例报告:水痘-带状疱疹病毒在一个家庭中引起的多种临床表现
Front Pediatr. 2022 Jun 6;10:876250. doi: 10.3389/fped.2022.876250. eCollection 2022.
8
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling.利用数学模型估计韩国单剂水痘疫苗的效力。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2085468. doi: 10.1080/21645515.2022.2085468. Epub 2022 Jun 15.
9
Epidemiological characteristics of varicella outbreaks in the Republic of Korea, 2016-2020.2016 - 2020年韩国水痘暴发的流行病学特征
Osong Public Health Res Perspect. 2022 Apr;13(2):133-141. doi: 10.24171/j.phrp.2022.0087. Epub 2022 Apr 26.
10
Seroprevalence comparison of different varicella vaccines among Turkish children.土耳其儿童中不同水痘疫苗的血清流行率比较
Hum Vaccin Immunother. 2022 Nov 30;18(5):2067443. doi: 10.1080/21645515.2022.2067443. Epub 2022 Apr 21.

本文引用的文献

1
Effectiveness and impact of a single-dose vaccine against chickenpox in the community of Madrid between 2001 and 2015.2001 年至 2015 年间马德里社区中一剂水痘疫苗的有效性和影响。
Hum Vaccin Immunother. 2018;14(9):2274-2280. doi: 10.1080/21645515.2018.1475813. Epub 2018 Jun 22.
2
Validation of Herpes Zoster Diagnosis Code in the Electronic Medical Record: A Retrospective, Multicenter Study.电子病历中带状疱疹诊断编码的验证:一项回顾性多中心研究
Ann Dermatol. 2018 Apr;30(2):253-255. doi: 10.5021/ad.2018.30.2.253. Epub 2018 Feb 21.
3
Varicella vaccination - the global experience.水痘疫苗——全球经验
Expert Rev Vaccines. 2017 Aug;16(8):833-843. doi: 10.1080/14760584.2017.1343669. Epub 2017 Jul 13.
4
Estimation of age-specific rates of reactivation and immune boosting of the varicella zoster virus.水痘带状疱疹病毒特定年龄再激活率和免疫增强率的估计。
Epidemics. 2017 Jun;19:1-12. doi: 10.1016/j.epidem.2016.11.001. Epub 2016 Nov 22.
5
The burden of chickenpox disease in Sweden.瑞典水痘疾病的负担。
BMC Infect Dis. 2016 Nov 10;16(1):666. doi: 10.1186/s12879-016-1957-5.
6
Effectiveness of Varicella Vaccination Program in Preventing Laboratory-Confirmed Cases in Children in Seoul, Korea.韩国首尔水痘疫苗接种计划在预防儿童实验室确诊病例方面的有效性。
J Korean Med Sci. 2016 Dec;31(12):1897-1901. doi: 10.3346/jkms.2016.31.12.1897.
7
Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.接种疫苗的韩国儿童和MAV疫苗组中水痘带状疱疹病毒血清阳性情况。
Hum Vaccin Immunother. 2016 Oct 2;12(10):2560-2564. doi: 10.1080/21645515.2016.1190056. Epub 2016 Aug 2.
8
Global Varicella Vaccine Effectiveness: A Meta-analysis.全球水痘疫苗效力:荟萃分析。
Pediatrics. 2016 Mar;137(3):e20153741. doi: 10.1542/peds.2015-3741. Epub 2016 Feb 16.
9
Awareness, Knowledge, and Vaccine Acceptability of Herpes Zoster in Korea: A Multicenter Survey of 607 Patients.韩国带状疱疹的认知、知识及疫苗可接受性:对607名患者的多中心调查
Ann Dermatol. 2015 Oct;27(5):531-8. doi: 10.5021/ad.2015.27.5.531. Epub 2015 Oct 2.
10
Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based Study.加拿大安大略省20年有医疗护理的儿童水痘和带状疱疹:一项基于人群的研究。
PLoS One. 2015 Jul 15;10(7):e0129483. doi: 10.1371/journal.pone.0129483. eCollection 2015.

韩国实施十余年水痘单剂疫苗普遍接种前后(2003-2015 年)水痘和带状疱疹流行病学趋势。

Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015.

机构信息

Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Vaccine Bio Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

Hum Vaccin Immunother. 2019;15(11):2554-2560. doi: 10.1080/21645515.2019.1603985. Epub 2019 May 7.

DOI:10.1080/21645515.2019.1603985
PMID:31008679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6930048/
Abstract

: In South Korea, the one-dose varicella vaccine was included in the National Immunization Program for children aged 12-15 months in 2005, and the vaccine coverage reached >95%. The impact of varicella vaccination on varicella and herpes zoster (HZ) was investigated, accounting for demographic changes over time.: We calculated the crude and age-sex standardized incidence rates (IRs) and age-specific IRs of varicella and HZ from 2003 to 2015, using the National Health Information Database including approximately 50 million Koreans. The annual incidence rate ratios (IRRs) were calculated using a negative binomial regression analysis, adjusting for age and sex.: The crude varicella IR steadily declined by 67%, from 5.70/1000 to 1.87/1000 person years (IRR per year: 0.91; 95% CI 0.89-0.93), but the adjusted IRs showed a significant decline only during 2010-2015 (adjusted IRR per year: 0.90; 95% CI 0.88-0.93). The greatest decline was found in children ≤4 years of age, whereas the IR increased until 2011 and then declined afterward in children aged 5-9 years, who represented the highest incidence age group in 2013-2015. The crude HZ IR increased from 2.67/1000 to 9.80/1000 person years (IRR per year: 1.12; 95% CI 1.10-1.15), and the adjusted IR also followed the same trend. A similar increasing trend was observed before and after universal vaccination.: One-dose varicella vaccination was moderately effective in preventing varicella, but this strategy was insufficient to interrupt varicella transmission in children. Furthermore, the HZ incidence dramatically increased over this decade. The current vaccination strategy against varicella-zoster disease should be reconsidered.

摘要

: 在韩国,2005 年将一剂水痘疫苗纳入了 12-15 月龄儿童的国家免疫规划,疫苗覆盖率达到>95%。本研究旨在评估水痘疫苗接种对水痘和带状疱疹(herpes zoster,HZ)的影响,同时考虑了随时间变化的人口统计学因素。: 我们利用包含约 5000 万韩国人的国家健康信息数据库,计算了 2003 年至 2015 年水痘和 HZ 的粗发病率和年龄性别标准化发病率(incidence rate,IR)以及年龄特异性 IR。采用负二项回归分析计算发病率比(incidence rate ratio,IRR),并按年龄和性别进行校正。: 水痘的粗发病率持续下降 67%,从 5.70/1000 人年降至 1.87/1000 人年(每年发病率比:0.91;95%CI 0.89-0.93),但仅在 2010-2015 年调整后的发病率呈显著下降(每年调整后发病率比:0.90;95%CI 0.88-0.93)。发病率下降最大的是≤4 岁儿童,而 5-9 岁儿童的发病率在 2011 年之前增加,随后在 2013-2015 年降至最低。HZ 的粗发病率从 2.67/1000 人年增至 9.80/1000 人年(每年发病率比:1.12;95%CI 1.10-1.15),调整后的发病率也呈现相同趋势。在普遍接种水痘疫苗前后均观察到类似的上升趋势。: 一剂水痘疫苗在预防水痘方面具有中等效力,但该策略不足以阻断儿童中的水痘传播。此外,在过去十年中,HZ 的发病率显著增加。目前针对水痘-带状疱疹疾病的疫苗接种策略应重新考虑。